Imunon, Inc.

Imunon, Inc. (IMNN) is a United States-based biopharmaceutical company focused on developing and commercializing innovative immunotherapies for the treatment of cancer. The company's research and development efforts are centered on harnessing the power of the immune system to fight cancer cells. Imunon's proprietary platform aims to stimulate a robust and targeted immune response against tumors. By leveraging its expertise in immunotherapy, Imunon seeks to address unmet medical needs in various cancer indications. The company's pipeline includes investigational therapies designed to enhance patient outcomes and improve the quality of life for individuals affected by cancer. Imunon operates within the biotechnology sector, contributing to advancements in cancer treatment through its innovative approach to immunotherapy.